FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

JB Chemicals and Pharmaceuticals Enalapril Maleate Tablets Recall

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Un…

JB Chemicals and Pharmaceuticals Ltd

Risk level
Class II
Reported by FDA
May 13, 2026
Recall ID
D-0520-2026
Check your lot numberHow we source this data

Summary

JB Chemicals and Pharmaceuticals recalled Enalapril Maleate Tablets starting Apr 23, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0520-2026 on May 13, 2026. Reason: Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Product description

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

Lot numbers, UPCs & expiration codes

Lot #: GEH25023, Expires: 6/30/2027

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0520-2026
Classification
Class II
Status
Ongoing
Recall initiated
Apr 23, 2026
FDA report date
May 13, 2026
Quantity
675 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
JB Chemicals and Pharmaceuticals Ltd

Original FDA data

Every field from FDA enforcement report D-0520-2026, exactly as published.

Show all FDA fields
City
Mumbai
Status
Ongoing
Country
India
Event ID
98794
Address
Neelam Centre A Wing A B Wing
Address (line 2)
4th Floor; Hind Cycle Road
Code information
Lot #: GEH25023, Expires: 6/30/2027
Report date
May 13, 2026
Product type
Drugs
Recall number
D-0520-2026
Classification
Class II
Recalling firm
JB Chemicals and Pharmaceuticals Ltd
Product quantity
675 bottles
Reason for recall
Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 23, 2026
Initial firm notification
Letter
Center classification date
May 5, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0520-2026, published May 13, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls